Cross Country Healthcare Stock News

Cross Country Healthcare Inc. (NASDAQ:CCRN) has a beta value of 1.08 and has seen 1.19 million shares traded in the last trading session. The company, currently valued at $948.82M, closed the last trade at $26.16 per share which meant it lost -$1.06 on the day or -3.89% during that session. The CCRN stock price is Cross Country Healthcare Inc. (CCRN) Suffers From Weak Fundamental Momentum Read More »

Staffing Firms Look to Continue Outperformance in 2022

Qurates most recent research report on Medical Staffing was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on Medical Staffing is extensive and consist of over 120

California State Teachers Retirement System cut its stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 8.0% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 49,468 shares of the business services providers stock after selling 4,304 shares during the period. California State Teachers Retirement Systems []

We have narrowed our search to five staffing stocks that have popped in the past three months. These are: KFRC, KFY, CCRN, RHI and RGP.

Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Cross Country Healthcare (NASDAQ:CCRN) had its target price upped by Barrington Research from $22.00 to $33.00 in a research note issued to investors on Thursday morning, The Fly reports. They currently have an outperform rating on the business services providers stock. CCRN has been the topic of a number of other research reports. Zacks Investment []

Brokerages expect that Cross Country Healthcare, Inc. (NASDAQ:CCRN) will announce $587.05 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Cross Country Healthcares earnings, with the highest sales estimate coming in at $588.95 million and the lowest estimate coming in at $585.15 million. Cross Country Healthcare reported []

Nuveen Asset Management LLC boosted its position in Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 7.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 286,798 shares of the business services providers stock after acquiring an additional 20,071 shares during the period. Nuveen Asset Management LLC owned 0.75% []

Cross Country Healthcare (NASDAQ:CCRN)‘s stock had its “outperform” rating restated by research analysts at Barrington Research in a note issued to investors on Thursday, The Fly reports. They presently have a $33.00 target price on the business services provider’s stock, up from their previous target price of $22.00. Barrington Research’s price target would suggest a […]

Northern Trust Corp cut its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 2.4% in the second quarter, Holdings Channel reports. The firm owned 406,078 shares of the business services providers stock after selling 10,176 shares during the period. Northern Trust Corps holdings in Cross Country Healthcare were worth $6,705,000 as of its most recent []

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) have been given a consensus recommendation of Buy by the eight analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month target price among brokerages that have []

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Cross Country Healthcare (CCRN).

For lucrative returns, investors should add broker-friendly stocks like C.H. Robinson (CHRW), Atlas Air (AAWW) Bunge (BG), Arch Resources (ARCH) and Cross Country Healthcare (CCRN) to their portfolio.

DFIN, CCRN, and EXPD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 10, 2021.